NORTH AMERICA VETERINARY VACCINES MARKET 2022-2028
TABLE OF CONTENTS
1.
NORTH AMERICA
VETERINARY VACCINES MARKET – SUMMARY
2.
INDUSTRY
OUTLOOK
2.1. IMPACT OF COVID-19 ON THE VETERINARY VACCINES
MARKET
2.2. KEY INSIGHTS
2.2.1.
INCREASING
INNOVATION BY MARKET PARTICIPANTS
2.2.2.
ADVANCEMENTS
IN VACCINE AND DIAGNOSTIC TECHNOLOGY
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1.
THREAT OF NEW
ENTRANTS
2.3.2.
THREAT OF
SUBSTITUTES
2.3.3.
BARGAINING
POWER OF BUYERS
2.3.4.
BARGAINING
POWER OF SUPPLIERS
2.3.5.
THREAT OF
COMPETITIVE RIVALRY
2.4. MARKET ATTRACTIVENESS INDEX
2.5. VALUE CHAIN ANALYSIS
2.6. KEY BUYING CRITERIA
2.7. REGULATORY FRAMEWORK
2.8. VENDOR SCORECARD
2.9. KEY MARKET STRATEGIES
2.9.1.
MERGERS &
ACQUISITIONS
2.9.2.
CONTRACTS
& AGREEMENTS
2.9.3.
PRODUCT
LAUNCHES
2.9.4.
EXPANSIONS
& DIVESTITURES
2.10.
MARKET DRIVERS
2.10.1.
HIGH VACCINE
DEMAND DUE TO INCREASING ANIMAL POPULATION AND DISEASES
2.10.2.
GOVERNMENT-ORGANIZED
VACCINATION DRIVES
2.10.3.
ADVANCED
VACCINE RESEARCH AND DEVELOPMENT
2.11.
MARKET
CHALLENGES
2.11.1.
LACK OF
AWARENESS AND SCARCITY OF SKILLED VETERINARIANS
2.11.2.
STRINGENT
RULES AND REGULATIONS PERTAINING TO VACCINE USE
2.12.
MARKET
OPPORTUNITIES
2.12.1.
GROWING USE OF
VACCINES IN THE AMERICAN MARKET
2.12.2.
RISING DEMAND
FOR COMPANION ANIMALS
3.
NORTH AMERICA
VETERINARY VACCINES MARKET OUTLOOK – BY ANIMAL TYPE
3.1. LIVESTOCK ANIMALS
3.1.1.
CATTLE
3.1.2.
PIGS
3.1.3.
POULTRY
3.1.4.
SHEEP
3.1.5.
OTHER
LIVESTOCK ANIMALS
3.2. COMPANION ANIMALS
3.2.1.
CANINE
3.2.2.
FELINE
3.2.3.
EQUINE
3.3. AQUACULTURE
4.
NORTH AMERICA
VETERINARY VACCINES MARKET OUTLOOK – BY DISEASE TYPE
4.1. CANINE DISEASE
4.2. PORCINE DISEASE
4.3. BOVINE DISEASE
4.4. POULTRY DISEASE
4.5. AQUACULTURE DISEASE
4.6. OTHER DISEASE TYPES
5.
NORTH AMERICA
VETERINARY VACCINES MARKET OUTLOOK – BY PRODUCT TYPE
5.1. ATTENUATED VACCINES
5.2. INACTIVATED VACCINES
5.3. TOXOID VACCINES
5.4. CONJUGATE VACCINES
5.5. DNA VACCINES
5.6. RECOMBINANT VACCINES
5.7. SUBUNIT VACCINES
6.
NORTH AMERICA
VETERINARY VACCINES MARKET – COUNTRY OUTLOOK
6.1. UNITED STATES
6.2. CANADA
7.
COMPETITIVE
LANDSCAPE
7.1. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
7.2. BRILLIANT BIO PHARMA
7.3. CEVA SANTE ANIMALE
7.4. ELANCO ANIMAL HEALTH INC
7.5. HESTER BIOSCIENCES LTD
7.6. HIPRA
7.7. INDIAN IMMUNOLOGICALS LIMITED
7.8. MERCK ANIMAL HEALTH
7.9. PHIBRO ANIMAL HEALTH
7.10.
VAXXINOVA GMBH
7.11.
VIRBAC SA
7.12.
ZOETIS INC
8.
RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE & DELIVERABLES
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY
TABLE LIST
TABLE 1: NORTH
AMERICA VETERINARY VACCINES MARKET, BY COUNTRY, 2022-2028 (IN $ MILLION)
TABLE 2: REGULATORY
FRAMEWORK
TABLE 3: VENDOR
SCORECARD
TABLE 4: NORTH
AMERICA VETERINARY VACCINES MARKET, BY ANIMAL TYPE, 2022-2028 (IN $ MILLION)
TABLE 5: NORTH
AMERICA VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMALS, 2022-2028 (IN $
MILLION)
TABLE 6: NORTH
AMERICA VETERINARY VACCINES MARKET, BY COMPANION ANIMALS, 2022-2028 (IN $
MILLION)
TABLE 7: NORTH
AMERICA VETERINARY VACCINES MARKET, BY DISEASE TYPE, 2022-2028 (IN $ MILLION)
TABLE 8: NORTH
AMERICA VETERINARY VACCINES MARKET, BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)
TABLE 9: NORTH
AMERICA VETERINARY VACCINES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
FIGURE LIST
FIGURE 1: MARKET
ATTRACTIVENESS INDEX
FIGURE 2: VALUE CHAIN
ANALYSIS
FIGURE 3: KEY BUYING
CRITERIA
FIGURE 4: NORTH
AMERICA VETERINARY VACCINES MARKET, BY ANIMAL TYPE, 2021 & 2028 (IN %)
FIGURE 5: NORTH
AMERICA VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMALS, 2022-2028 (IN $
MILLION)
FIGURE 6: NORTH
AMERICA VETERINARY VACCINES MARKET, BY LIVESTOCK ANIMALS, 2021 & 2028 (IN
%)
FIGURE 7: NORTH
AMERICA VETERINARY VACCINES MARKET, BY CATTLE, 2022-2028 (IN $ MILLION)
FIGURE 8: NORTH
AMERICA VETERINARY VACCINES MARKET, BY PIGS, 2022-2028 (IN $ MILLION)
FIGURE 9: NORTH
AMERICA VETERINARY VACCINES MARKET, BY POULTRY, 2022-2028 (IN $ MILLION)
FIGURE 10: NORTH
AMERICA VETERINARY VACCINES MARKET, BY SHEEP, 2022-2028 (IN $ MILLION)
FIGURE 11: NORTH AMERICA
VETERINARY VACCINES MARKET, BY OTHER LIVESTOCK ANIMALS, 2022-2028 (IN $
MILLION)
FIGURE 12: NORTH
AMERICA VETERINARY VACCINES MARKET, BY COMPANION ANIMALS, 2022-2028 (IN $
MILLION)
FIGURE 13: NORTH
AMERICA VETERINARY VACCINES MARKET, BY COMPANION ANIMALS, 2021 & 2028 (IN
%)
FIGURE 14: NORTH
AMERICA VETERINARY VACCINES MARKET, BY CANINE, 2022-2028 (IN $ MILLION)
FIGURE 15: NORTH
AMERICA VETERINARY VACCINES MARKET, BY FELINE, 2022-2028 (IN $ MILLION)
FIGURE 16: NORTH
AMERICA VETERINARY VACCINES MARKET, BY EQUINE, 2022-2028 (IN $ MILLION)
FIGURE 17: NORTH
AMERICA VETERINARY VACCINES MARKET, BY AQUACULTURE, 2022-2028 (IN $ MILLION)
FIGURE 18: NORTH
AMERICA VETERINARY VACCINES MARKET, BY DISEASE TYPE, 2021 & 2028 (IN %)
FIGURE 19: NORTH
AMERICA VETERINARY VACCINES MARKET, BY CANINE DISEASE, 2022-2028 (IN $ MILLION)
FIGURE 20: NORTH
AMERICA VETERINARY VACCINES MARKET, BY PORCINE DISEASE, 2022-2028 (IN $
MILLION)
FIGURE 21: NORTH
AMERICA VETERINARY VACCINES MARKET, BY BOVINE DISEASE, 2022-2028 (IN $ MILLION)
FIGURE 22: NORTH
AMERICA VETERINARY VACCINES MARKET, BY POULTRY DISEASE, 2022-2028 (IN $
MILLION)
FIGURE 23: NORTH
AMERICA VETERINARY VACCINES MARKET, BY AQUACULTURE DISEASE, 2022-2028 (IN $
MILLION)
FIGURE 24: NORTH
AMERICA VETERINARY VACCINES MARKET, BY OTHER DISEASE TYPE, 2022-2028 (IN $
MILLION)
FIGURE 25: NORTH
AMERICA VETERINARY VACCINES MARKET, BY PRODUCT TYPE, 2021 & 2028 (IN %)
FIGURE 26: NORTH
AMERICA VETERINARY VACCINES MARKET, BY ATTENUATED VACCINES, 2022-2028 (IN $
MILLION)
FIGURE 27: NORTH AMERICA
VETERINARY VACCINES MARKET, BY INACTIVATED VACCINES, 2022-2028 (IN $ MILLION)
FIGURE 28: NORTH
AMERICA VETERINARY VACCINES MARKET, BY TOXOID VACCINES, 2022-2028 (IN $
MILLION)
FIGURE 29: NORTH
AMERICA VETERINARY VACCINES MARKET, BY CONJUGATE VACCINES, 2022-2028 (IN $
MILLION)
FIGURE 30: NORTH
AMERICA VETERINARY VACCINES MARKET, BY DNA VACCINES, 2022-2028 (IN $ MILLION)
FIGURE 31: NORTH
AMERICA VETERINARY VACCINES MARKET, BY RECOMBINANT VACCINES, 2022-2028 (IN $
MILLION)
FIGURE 32: NORTH
AMERICA VETERINARY VACCINES MARKET, BY SUBUNIT VACCINES, 2022-2028 (IN $
MILLION)
FIGURE 33: NORTH
AMERICA VETERINARY VACCINES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 34: UNITED
STATES VETERINARY VACCINES MARKET 2022-2028 (IN $ MILLION)
FIGURE 35: CANADA VETERINARY
VACCINES MARKET 2022-2028 (IN $ MILLION)
MARKET OUTLOOK
Triton
Market Research’s study shows the probable growth of the veterinary vaccines
market in North America at a CAGR of 6.91% over the years 2022 to 2028. The
United States and Canada highlight the overall progress within the region.
The
North American veterinary vaccines market showed a robust growth given the rise
in animal diseases, increased R&D, and other government incentives.
The
United States is among the leading countries in the veterinary vaccines market.
The demand for vaccines in the country is expanding due to a mass livestock
population. In this regard, major leading players like Merck Animal Health and
Zoetis Inc provide robust solutions to vaccinate livestock. Moreover, the
country has the largest population of companion animals, making it one of the
biggest markets for vaccine producers. These factors boost the growth process
of the veterinary vaccines market.
Likewise,
Canada’s veterinary vaccines market is likely to grow due to the rising
companion animal population. Additionally, there is an increasing risk of
animal disease due to abundant livestock. As such, the government of Canada is
largely supporting the vaccine market players through investments in more than 5,000
projects, which has improved the veterinary services. Therefore, the growing
agricultural sector is expected to provide ample opportunities for the
veterinary vaccines market in Canada.
Get more Insights into the
North America Veterinary Vaccines Market:
https://www.tritonmarketresearch.com/reports/north-america-veterinary-vaccines-market
COMPETITIVE OUTLOOK
The
prominent companies contributing to the growth of the veterinary vaccines
market include Merck Animal Health, Phibro Animal Health, Vaxxinova GmbH,
Hester Biosciences Ltd, Elanco Animal Health Inc, and Ceva Sante Animale.
SEGMENTATION
1.
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
2.
BRILLIANT BIO
PHARMA
4.
ELANCO ANIMAL
HEALTH INC
5.
HESTER
BIOSCIENCES LTD
6.
HIPRA
7.
INDIAN
IMMUNOLOGICALS LIMITED
8.
MERCK ANIMAL
HEALTH
9.
PHIBRO ANIMAL
HEALTH
10. VAXXINOVA GMBH
11. VIRBAC SA
12. ZOETIS INC
Comments
Post a Comment